.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Argus Health
Dow
Medtronic
Teva
Johnson and Johnson
Julphar
Cipla
Citi
Chubb

Generated: July 23, 2017

DrugPatentWatch Database Preview

BICILLIN Drug Profile

« Back to Dashboard

Which patents cover Bicillin, and what generic Bicillin alternatives are available?

Bicillin is a drug marketed by Wyeth Ayerst and King Pharms Llc and is included in five NDAs.

The generic ingredient in BICILLIN is penicillin g benzathine; penicillin g procaine. There are eighty-seven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the penicillin g benzathine; penicillin g procaine profile page.

Summary for Tradename: BICILLIN

Patents:0
Applicants:2
NDAs:5
Bulk Api Vendors: see list24
Clinical Trials: see list2
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:BICILLIN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Ayerst
BICILLIN
penicillin g benzathine
SUSPENSION;ORAL050126-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
King Pharms Llc
BICILLIN L-A
penicillin g benzathine
INJECTABLE;INJECTION050141-003Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe
King Pharms Llc
BICILLIN C-R
penicillin g benzathine; penicillin g procaine
INJECTABLE;INJECTION050138-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe
King Pharms Llc
BICILLIN L-A
penicillin g benzathine
INJECTABLE;INJECTION050141-001Approved Prior to Jan 1, 1982BCRXYesYes► Subscribe► Subscribe
Wyeth Ayerst
BICILLIN
penicillin g benzathine
TABLET;ORAL050128-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Deloitte
Moodys
Novartis
Queensland Health
Chinese Patent Office
Dow
Citi
Harvard Business School
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot